These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 27298100)

  • 21. Surgical resection and liver transplantation for hepatocellular carcinoma.
    Akoad ME; Pomfret EA
    Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current surgical treatment strategies for hepatocellular carcinoma in North America.
    Khan AS; Fowler KJ; Chapman WC
    World J Gastroenterol; 2014 Nov; 20(41):15007-17. PubMed ID: 25386049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current strategies for preventing the recurrence of hepatocellular carcinoma after liver transplantation.
    Wang ZY; Geng L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):145-9. PubMed ID: 25865686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic therapies for hepatocellular carcinoma.
    Ge S; Huang D
    Drug Discov Ther; 2015 Oct; 9(5):352-62. PubMed ID: 26632544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm.
    Richani M; Kolly P; Knoepfli M; Herrmann E; Zweifel M; von Tengg-Kobligk H; Candinas D; Dufour JF
    Ann Hepatol; 2016; 15(1):82-90. PubMed ID: 26626644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis.
    Zhu GQ; Shi KQ; Yu HJ; He SY; Braddock M; Zhou MT; Chen YP; Zheng MH
    Oncotarget; 2015 Jul; 6(20):18151-61. PubMed ID: 26061709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.
    Tagliamonte M; Mauriello A; Cavalluzzo B; Ragone C; Manolio C; Petrizzo A; Buonaguro L
    Cancer Lett; 2020 Mar; 473():25-32. PubMed ID: 31875523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
    Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R
    Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current management of hepatocellular carcinoma.
    Mendizabal M; Reddy KR
    Med Clin North Am; 2009 Jul; 93(4):885-900, viii. PubMed ID: 19577120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multimodal treatment of hepatocellular carcinoma].
    Kirstein MM; Wirth TC
    Internist (Berl); 2020 Feb; 61(2):164-169. PubMed ID: 31919533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.
    Tung-Ping Poon R; Fan ST; Wong J
    Ann Surg; 2000 Jul; 232(1):10-24. PubMed ID: 10862190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma--rising incidence, changing therapeutic strategies.
    Müller C
    Wien Med Wochenschr; 2006 Jul; 156(13-14):404-9. PubMed ID: 16937043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of hepatocellular cancer.
    Mulcahy MF
    Curr Treat Options Oncol; 2005 Sep; 6(5):423-35. PubMed ID: 16107245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical options for hepatocellular carcinoma: resection and transplantation.
    Olthoff KM
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S98-104. PubMed ID: 9742501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant therapy for hepatocellular carcinoma after curative treatment.
    Jeng WJ; Lin CC; Chen WT; Sheen IS; Lin CY; Lin SM
    Dig Dis; 2014; 32(6):747-54. PubMed ID: 25376293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene- and immunotherapy for hepatocellular carcinoma.
    Palmer DH; Hussain SA; Johnson PJ
    Expert Opin Biol Ther; 2005 Apr; 5(4):507-23. PubMed ID: 15934829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multidisciplinary management of hepatocellular carcinoma in cirrhotic patients].
    Lucidi V; Katsanos G; Buggenhout A; Moreno C; Gustot T; Boon N; Degré D; Bourgeois N; Brisbois D; Bali MA; Demetter P; Van Laethem JL; Donckier V
    Rev Med Brux; 2012 Sep; 33(4):229-36. PubMed ID: 23091926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal therapy for hepatocellular carcinoma: a complementary approach to liver transplantation.
    Schumacher PA; Powell JJ; MacNeill AJ; Buczkowski AK; Erb SR; Ho SG; Scudamore CH; Steinbrecher UP; Weiss A; Yoshida E; Chung SW
    Ann Hepatol; 2010; 9(1):23-32. PubMed ID: 20308719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.